EGFR and glioblastoma: Our research team has successfully developed a sophisticated complex by combining epidermal growth factor receptor siRNA with cyclic Arg-Gly-Asp (cRGD) peptide, enabling specific targeting of GBM cells that overexpress αvβ3 integrin [50].